Pharmaceutical Technology-04-02-2015

Pharmaceutical Technology

The Role of Regulatory Advice in Drug Development

April 02, 2015

Regulatory Watch

39

4

Drug developers understand the importance of early communication with regulators, but is EMA providing enough flexibility and support to companies?

The Human Microbiome Project and Pharmaceutical Quality Control Microbiology

April 02, 2015

Peer-Reviewed Research

39

4

The Human Microbiome Project has increased our understanding of the relationship between humans and microorganisms. The authors offer a new perspective on how this knowledge should be considered in setting standards for pharmaceutical quality control in microbiology.

Welcome to the Biosimilar Era

April 02, 2015

From The Editor

39

4

FDA approves a biosimilar and loses a commissioner in March.

Modern Manufacturing Systems Key to FDA Quality Initiative

April 02, 2015

Regulatory Watch

39

4

More reliable operations would accelerate product development and prevent drug shortages.

Multivariate Data Analysis Finds Use In Biopharmaceutical Process Development And Scale-Up

April 02, 2015

39

4

Multivariate data analysis (MVDA) is being used to effectively handle complex datasets generated by process analytical technology (PAT) in biopharmaceutical process development and manufacturing.

Pharmaceutical Technology, April 2015 Issue (PDF)

April 02, 2015

Issue PDF

39

4

Click the title above to open the Pharmaceutical Technology April 2015 issue in an interactive PDF format.